VANCOUVER, BC / ACCESSWIRE / December 8, 2016 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the addition of
VANCOUVER, BC / ACCESSWIRE / November 30, 2016 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces partnership with Dr.
VANCOUVER, BC / ACCESSWIRE / November 22, 2016 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce
VANCOUVER, BC / ACCESSWIRE / November 15, 2016 / CVR Medical Corp. (CVM.V) (“CVR Medical“) is pleased to announce that CVR Global, its joint venture
VANCOUVER, BC / ACCESSWIRE / November 2, 2016 / CVR Medical Corp. (CVM.V) (“CVR Medical“) has entered into agreements with Tekna Incorporated, who will design
October 20, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) has appointed Dr. Paul S. Blunden to its Board of Directors.
CVR Medical Corp (CVM.V) (Previously Big Bar Resources Corp) shares resumed trading on September 27, 2016 following TSX Venture Exchange Inc. acceptance of the previously
October 12, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) is pleased to announce that it has entered into an agreement
Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) is pleased to announce that it has entered into a consulting agreement effective as of
September 27, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (the “Company”) is pleased to announce it resumed trading on the TSX Venture
September 16, 2016 – Vancouver, British Columbia (NEX Board of TSX-V: BBR.H) Big Bar Resources Corporation (“Big Bar” or the “Company”) is pleased to announce
September 15, 2016 – Vancouver, British Columbia (NEX Board of TSX-V: BBR.H) Big Bar Resources Corporation (“Big Bar” or the “Company”) is pleased to report
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.